Ginkgo Bioworks Holdings Inc (DNA)
0.8356
-0.01
(-0.77%)
USD |
NYSE |
May 02, 11:21
Ginkgo Bioworks Holdings Gross Profit Margin (Quarterly): 80.98% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 80.98% |
| September 30, 2023 | 87.51% |
| June 30, 2023 | 77.54% |
| March 31, 2023 | 72.27% |
| December 31, 2022 | 69.25% |
| September 30, 2022 | 62.87% |
| June 30, 2022 | 55.81% |
| Date | Value |
|---|---|
| March 31, 2022 | 49.27% |
| December 31, 2021 | 55.16% |
| September 30, 2021 | 71.26% |
| June 30, 2021 | 60.79% |
| March 31, 2021 | 46.25% |
| December 31, 2020 | 56.82% |
| September 30, 2020 | 86.70% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
46.25%
Minimum
Mar 2021
87.51%
Maximum
Sep 2023
66.61%
Average
66.06%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus Inc | 20.07% |
| Teladoc Health Inc | 69.89% |
| Sarepta Therapeutics Inc | 88.87% |
| Ultragenyx Pharmaceutical Inc | 90.54% |
| Apellis Pharmaceuticals Inc | 86.40% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -62.03% |
| Return on Assets | -40.81% |
| Return on Invested Capital | -62.03% |
| Profit Margin (Quarterly) | -609.1% |
| Operating Margin (Quarterly) | -512.5% |
| Return on Net Operating Assets | -105.3% |